BD-CareFusion deal passes US anti-trust waiting period

Becton Dickinson's $12.2 billion bid for device maker CareFusion clears the required waiting period under U.S. anti-trust regulations.

Becton Dickinson & Co., CareFusion Corp.

News Well, Mergers & Acquisitions

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1qHxjIT